JAZZ Venture Partners

JAZZ Venture Partners is a venture capital firm founded in 2015 and headquartered in San Francisco, California, with additional offices in Santa Monica and Seattle. The firm specializes in growth capital investments within the technology sector, particularly at the intersection of digital technology and neuroscience. JAZZ Venture Partners focuses on companies that leverage advanced brain science to develop innovative technology platforms in areas such as virtual and augmented reality, immersive gaming, artificial intelligence, and closed-loop human-computer systems. The firm aims to enhance human performance across various markets, including health, mind-body wellness, peak mental and physical performance, and accelerated learning. The team comprises experienced investors, entrepreneurs, neuroscientists, and technologists, providing a unique blend of expertise and resources to support exceptional entrepreneurs in building transformative companies.

Stone Connell

Vice President of Finance

Sydney Cureton

Senior Associate

Sujude Dalieh

Senior Associate

Andrew Firlik

Co-Founder and Managing Partner

Narie Foster

Venture Partner

Sharon Knight

Venture Partner

John Lee

Partner

Zack Lynch

Co-Founder and Managing Partner

Justin Nuñez

Partner

Meghan Reynolds

Venture Partner

John Spinale

Co-Founder and Managing Partner

Elan Tye

Principal

Allison Williams

Principal

82 past transactions

Justpoint

Series A in 2025
Justpoint is an artificial intelligence-powered platform designed to connect individuals with suitable litigation attorneys and streamline the management of personal injury claims. By leveraging predictive analytics, Justpoint enhances transparency and efficiency in the attorney selection process, moving away from traditional advertising methods. The platform supports plaintiffs in identifying legitimate claims and retaining the right legal representation while assisting law firms in assessing the merits of cases more quickly. Operating in 33 states and collaborating with over 1,000 law firms, Justpoint has access to more than 300,000 historical claims. Its team, comprising attorneys, engineers, and medical professionals, is committed to improving access to justice for those in need of legal assistance.

KLOWEN Braces

Series B in 2024
KLOWEN Braces, Inc. specializes in the development of custom braces systems designed for orthodontists and their patients. Established in 2019 and headquartered in Fort Collins, Colorado, the company utilizes an innovative software platform to ensure the precise placement of uniquely shaped brackets for each tooth. KLOWEN Braces offers a range of orthodontic components, including modular brackets, hooks, bundles, tubes, and wires, all available through online channels. Its systems aim to provide a faster, more effective, and more comfortable alternative to traditional braces, enhancing the overall orthodontic treatment experience.

Pinpoint Predictive

Series A in 2024
Pinpoint Predictive is a company that specializes in providing property and casualty insurers with advanced loss predictions and risk scores based solely on a customer's name and address. Its platform is designed to enhance risk selection at the initial stages of the customer journey by delivering actuarial predictions related to claims frequency, severity, and loss costs. Additionally, the platform offers risk scores that assist insurers in identifying cases for special investigations, managing litigation, addressing early cancellations, and reducing premium leakage. By enabling insurers to track consumer behavior and tailor their product offerings, Pinpoint Predictive enhances the overall efficiency and effectiveness of the underwriting process.

Enveda Biosciences

Series B in 2024
Enveda Biosciences is a biotechnology company that employs artificial intelligence-powered tools to investigate and define molecules sourced from living organisms. Its primary objective is to build an exhaustive database of chemical biodiversity, thereby expediting the discovery of novel medicines. The company's innovative drug discovery platform integrates machine learning, metabolomics, and robotics to analyze natural samples for both chemical structure and biological activity, eliminating the need for isolating individual compounds or extensive experimentation. This enables healthcare industry clients to develop a wide range of new medications, from antibiotics to hypotensives.

Bonito Biosciences

Seed Round in 2024
Bonito Biosciences is a biotechnology company focused on developing tissue-selective drug delivery systems for oligonucleotides and macromolecules. Their proprietary platform enables cell-specific delivery of RNA degraders, potentially improving the efficacy and safety of therapeutics for patients.

Transcripta Bio

Venture Round in 2024
Transcripta Bio, based in Palo Alto, California, specializes in pharmaceutical development using artificial intelligence. The company's core business involves generating new medicines for various diseases simultaneously, at an accelerated pace and with reduced risk. It offers services such as orchestrating gene expression, creating a drug-gene atlas, and predicting therapeutic genes, providing clients with a comprehensive view of genome-wide biological activity to aid in drug discovery.

Reken

Seed Round in 2024
Reken is an AI and cybersecurity firm established in 2024 and headquartered in San Francisco, California. The company is focused on developing innovative cybersecurity solutions designed to combat threats arising from generative AI, such as deepfake social engineering and automated fraud. Reken's platform aims to create a new category of AI products that employs a layered defense strategy. This approach combines zero trust principles with technological analysis of content, allowing users to effectively identify and mitigate malicious activities. Through its advancements, Reken seeks to enhance the security landscape in response to evolving digital threats.

Tomato.ai

Seed Round in 2023
Tomato.ai is a technology company that specializes in enhancing voice communication for offshore agents. Its core product uses artificial intelligence to "soften" accents, improving intelligibility and trust during conversations. Additionally, Tomato.ai offers advanced noise cancellation solutions to ensure clear communication. The company's software aims to facilitate more efficient agent calls, enabling businesses to hire more offshore agents, increase sales, reduce churn, and improve overall job accessibility.

HerMD

Series A in 2023
HerMD is a healthcare provider specializing in comprehensive health, beauty, and wellness services tailored specifically for women. Founded by Somi Javaid in 2019 and headquartered in Cincinnati, Ohio, the company offers a range of services including gynecology, menopause management, sexual medicine, obesity counseling, and various medical aesthetic treatments such as clinical facials and chemical peels. HerMD aims to create a safe and trusted environment where women can address their health and wellness needs, no matter how personal. By focusing on empowering women and providing holistic care, HerMD addresses both physical health and aesthetic concerns, helping clients improve their overall well-being and appearance.

Robust.AI

Series A in 2023
Robust.AI, founded by Anthony Jules in 2019 and based in San Carlos, California, specializes in developing a robot cognitive platform that aims to solve complex robotics problems and make mobile robots widely usable across various industries. The company's technology combines AI, robotics, and human-centered design to create collaborative mobile robots that are safe, autonomous, and easy to integrate into existing workflows. Robust.AI has introduced two key products: Grace, a software suite, and Carter, a hardware concept. These innovations are particularly targeted at the warehousing industry, where automation is currently underutilized despite significant labor shortages impacting global supply chains.

Zus Health

Series A in 2023
Zus Health is a healthcare technology company founded in 2020 by Jonathan Bush, based in Watertown, Massachusetts. It specializes in developing a healthcare data platform that accelerates the creation of digital health solutions. The platform uniquely integrates health and non-health information, allowing healthcare professionals to gain a comprehensive understanding of patients while sharing clinical and non-clinical data without requiring the same applications. By removing traditional barriers, Zus Health empowers a new generation of healthcare builders to design technologies and services that are more affordable and customizable, aiming to enhance the overall healthcare experience.

Cadence Neuroscience

Venture Round in 2023
Cadence Neuroscience, Inc. is an early-stage company founded in 2017 and headquartered in Redmond, Washington. It specializes in developing innovative medical device therapies aimed at treating epilepsy, central pain, and other neurological disorders. The company’s core technology, developed at the Mayo Clinic, is currently under clinical evaluation. Cadence Neuroscience's medical devices are designed to detect specific brain signals and deliver targeted electrical stimulation, allowing for tailored brain stimulation therapies. This approach enhances seizure control and aims to improve treatment outcomes for patients with neurological issues compared to existing protocols.

Revelata

Pre Seed Round in 2023
Revelata develops an artificial intelligence platform for extracting data from complex financial documents. It's first product, deepKPI, automatically surfaces hard-to-get KPI time series that are buried within billions of pages of SEC filings. The company was founded in 2020 and is headquartered in Palo Alto, California.

Colossal Laboratories & Biosciences

Series B in 2023
Colossal Laboratories & Biosciences is a bioscience and genetic engineering company dedicated to addressing extinction and biodiversity loss through innovative gene editing technologies, primarily CRISPR. The company focuses on reviving extinct species, such as the woolly mammoth, while also working to protect critically endangered species and restore vital ecosystems. By employing advanced genetic techniques, Colossal aims to create solutions that not only facilitate the repopulation of ecosystems but also contribute to the sustainability of life on Earth. Through its pioneering efforts, Colossal aspires to tackle pressing environmental challenges and support the future of both ecological health and human necessities.

Enveda Biosciences

Series B in 2022
Enveda Biosciences is a biotechnology company that employs artificial intelligence-powered tools to investigate and define molecules sourced from living organisms. Its primary objective is to build an exhaustive database of chemical biodiversity, thereby expediting the discovery of novel medicines. The company's innovative drug discovery platform integrates machine learning, metabolomics, and robotics to analyze natural samples for both chemical structure and biological activity, eliminating the need for isolating individual compounds or extensive experimentation. This enables healthcare industry clients to develop a wide range of new medications, from antibiotics to hypotensives.

Form Bio

Series A in 2022
Form Bio is a biotechnology company that focuses on enhancing scientific discovery by addressing the challenges related to data, computation, and technical aspects in life sciences. The company offers a comprehensive platform that integrates the entire discovery process, featuring intuitive software applications designed for workflows, data management, collaboration, and data visualization. This platform is aimed at lab directors, biotech firms, pharmaceutical companies, and academic institutions, providing them with the tools necessary to efficiently manage and utilize the growing volume of data and computing power in their research endeavors. By fostering an open and adaptable collaborative environment, Form Bio enables scientists to streamline their workflows and improve their overall productivity.

Form Bio

Series A in 2022
Form Bio is a biotechnology company that focuses on enhancing scientific discovery by addressing the challenges related to data, computation, and technical aspects in life sciences. The company offers a comprehensive platform that integrates the entire discovery process, featuring intuitive software applications designed for workflows, data management, collaboration, and data visualization. This platform is aimed at lab directors, biotech firms, pharmaceutical companies, and academic institutions, providing them with the tools necessary to efficiently manage and utilize the growing volume of data and computing power in their research endeavors. By fostering an open and adaptable collaborative environment, Form Bio enables scientists to streamline their workflows and improve their overall productivity.

Foresight Mental Health

Series C in 2022
Foresight Mental Health is a technology-driven provider of psychiatry and therapy services, operating a network of clinics dedicated to mental health and wellness. The company employs a diverse team that includes psychiatrists, therapists, and psychiatric nurse practitioners who deliver care directly to patients. Foresight enhances its treatment offerings through innovative technology developed in collaboration with software and biomedical engineers, aimed at transforming the mental healthcare experience. By utilizing comprehensive patient profiles and a database of scientific research, the company conducts detailed analyses that include genetic profiles and assessments of brain-chemical balance. This holistic approach enables Foresight to offer tailored treatments, ultimately helping patients achieve improved mental health and overall well-being.

JobGet

Series B in 2022
JobGet Inc. is a mobile hiring application and job search platform based in Boston, Massachusetts, established in 2017. It serves as a marketplace connecting employers and job seekers, facilitating direct communication through messaging, scheduling meetings, and conducting video interviews. The platform is particularly focused on the retail and hospitality industries, significantly accelerating the job search process by reducing the timeline from weeks to mere minutes. JobGet has gained recognition as a top-rated application on both iOS and Android, assisting thousands of job seekers in engaging with prominent employers.

Oma Fertility

Venture Round in 2022
Oma Fertility is a comprehensive fertility clinic that provides a range of fertility care services, including in-vitro fertilization (IVF), egg freezing, embryo transfer, egg donation, sperm donation, and gestational surrogacy. The clinic utilizes advanced technologies, including artificial intelligence, to enhance the selection process of sperm cells for IVF through its proprietary AI microscope, Oma Sperm InSight. By integrating top lab design and technology with personalized care, Oma Fertility aims to make fertility treatments more accessible and affordable for a diverse population. The clinic also collaborates with external partners, such as surrogate agencies and egg and sperm banks, to facilitate a seamless experience for individuals and couples seeking fertility assistance.

Swing Therapeutics

Series A in 2022
Swing Therapeutics is focused on developing innovative digital therapeutics aimed at improving the lives of individuals with chronic conditions. The company assembles a team of scientists, clinicians, and technologists who collaborate with leading researchers to create evidence-based treatments. These digital solutions are designed to empower patients, allowing them to manage their health more effectively and regain control over their illnesses. By providing transformative therapeutic options, Swing Therapeutics seeks to enhance the overall well-being of patients, enabling them to lead healthier and more fulfilling lives.

KLOWEN Braces

Series A in 2022
KLOWEN Braces, Inc. specializes in the development of custom braces systems designed for orthodontists and their patients. Established in 2019 and headquartered in Fort Collins, Colorado, the company utilizes an innovative software platform to ensure the precise placement of uniquely shaped brackets for each tooth. KLOWEN Braces offers a range of orthodontic components, including modular brackets, hooks, bundles, tubes, and wires, all available through online channels. Its systems aim to provide a faster, more effective, and more comfortable alternative to traditional braces, enhancing the overall orthodontic treatment experience.

Colossal Laboratories & Biosciences

Series A in 2022
Colossal Laboratories & Biosciences is a bioscience and genetic engineering company dedicated to addressing extinction and biodiversity loss through innovative gene editing technologies, primarily CRISPR. The company focuses on reviving extinct species, such as the woolly mammoth, while also working to protect critically endangered species and restore vital ecosystems. By employing advanced genetic techniques, Colossal aims to create solutions that not only facilitate the repopulation of ecosystems but also contribute to the sustainability of life on Earth. Through its pioneering efforts, Colossal aspires to tackle pressing environmental challenges and support the future of both ecological health and human necessities.

HerMD

Series A in 2022
HerMD is a healthcare provider specializing in comprehensive health, beauty, and wellness services tailored specifically for women. Founded by Somi Javaid in 2019 and headquartered in Cincinnati, Ohio, the company offers a range of services including gynecology, menopause management, sexual medicine, obesity counseling, and various medical aesthetic treatments such as clinical facials and chemical peels. HerMD aims to create a safe and trusted environment where women can address their health and wellness needs, no matter how personal. By focusing on empowering women and providing holistic care, HerMD addresses both physical health and aesthetic concerns, helping clients improve their overall well-being and appearance.

Augment AI

Seed Round in 2022
Augment AI is a technology company focused on enhancing productivity and simplifying daily tasks through innovative context-aware artificial intelligence. Its unique system learns individual preferences and priorities, allowing it to serve as an intelligent assistant that anticipates needs and streamlines workflows. The company's interactive assistants, known as Augments, are designed to remember user-specific information, facilitate note-taking, and highlight action items, thereby improving efficiency in professional settings. By integrating seamlessly with familiar applications, Augment AI empowers users to optimize their work processes and achieve greater effectiveness in their roles.

Yumi

Series B in 2021
Yumi is a company that specializes in providing science-based meal delivery services for infants and young children. It focuses on producing fresh, nutrient-dense, and low-sugar baby food designed to meet the dietary needs of various age groups. Yumi aims to help parents understand the nutritional value of what they are feeding their children, particularly during the crucial early years of development. By offering a convenient and health-oriented solution, Yumi supports parents in ensuring their children receive optimal nutrition for brain development and overall well-being.

Sounding Board

Series B in 2021
Sounding Board is a technology company that specializes in leadership development. It offers a platform that provides personalized coaching for leaders and managers, connecting them with qualified coaches via phone, video, and chat. The platform creates tailored development plans, automates administration tasks, and offers data visualization tools to track progress and measure impact. Sounding Board serves global enterprises across 11 countries, with a strong focus on user experience and high-quality coaching. It was founded in 2016 and is headquartered in Foster City, California.

AppliedVR

Series B in 2021
AppliedVR, Inc. is a Los Angeles-based company that specializes in virtual reality solutions aimed at enhancing patient experiences in healthcare, particularly for pain and anxiety management in settings such as hospitals and surgery centers. Founded in 2013, AppliedVR has established strategic partnerships with institutions like Cedars-Sinai and Children's Hospital Los Angeles. The company's flagship product, EaseVRx, is a pioneering VR-based prescription therapeutic that has received Breakthrough Device Designation from the FDA. This innovative treatment leverages principles of cognitive behavioral therapy and mindfulness to help patients manage chronic pain by changing their pain perception and fostering new coping skills. EaseVRx allows patients to self-administer therapy at home, facilitating remote care and improving access to effective pain management solutions. Through its clinically validated and comprehensive approach, AppliedVR seeks to address the complexities of chronic pain and enhance overall quality of life for patients.

Magnus Medical

Series A in 2021
Magnus Medical focuses on developing a closed-loop neuromodulation technology aimed at effectively treating intractable neurological and psychiatric disorders. The company's innovative brain stimulation technology has shown the ability to produce profound and rapid results by facilitating identifiable changes in brain networks. This approach enables individuals to manage their symptoms acutely while also working towards restoring and sustaining their mental health over the long term.

NextStep

Venture Round in 2021
NextStep is an information technology company based in Seattle, Washington, founded in 2018. It specializes in providing training and job placement services through a mobile application platform. The company's platform offers online certified nursing assistant (CNA) training and placement programs, as well as recruitment, training, and placement for various entry-level healthcare jobs such as community health workers, home health aides, and medical assistants. This enables individuals to quickly and affordably reskill themselves while helping employers in the healthcare sector find skilled employees.

Blue Note Therapeutics

Series A in 2021
Blue Note Therapeutics, established in 2018 and headquartered in San Francisco, specializes in digital therapeutics for mental health care within cancer patients. The company's platform delivers evidence-based interventions via software programs, enabling physicians to treat medical conditions as primary or supplementary therapies using mobile devices. Blue Note collaborates with medical researchers and patient advocacy groups to ensure its solutions reach a wide range of patients.

AllStripes

Series B in 2021
AllStripes is a healthcare technology company focused on accelerating the development of new treatments for rare diseases. The company has created a platform that enables the generation of regulatory-ready evidence, facilitating rare disease research and drug development. AllStripes operates a two-sided network that connects patients with rare diseases and advocacy groups to life science companies seeking new drug candidates. Through this network, patients can contribute their medical data and participate in treatment research online, while life science companies gain access to valuable data and insights to support their drug development efforts.

Mahana Therapeutics

Series B in 2021
Mahana Therapeutics, Inc. is a company focused on developing digital treatments for individuals with chronic health conditions, particularly gastrointestinal diseases. Its flagship offering, Parallel, is a clinically validated, minimal-contact digital program specifically designed for patients suffering from irritable bowel syndrome (IBS). The program aims to deliver both physical and psychological support to enhance patient well-being. Founded in 2018 and headquartered in San Francisco, California, Mahana Therapeutics also maintains an office in London, United Kingdom. The company was previously known as Mahana Health, Inc. before rebranding in July 2019.

Swing Therapeutics

Seed Round in 2021
Swing Therapeutics is focused on developing innovative digital therapeutics aimed at improving the lives of individuals with chronic conditions. The company assembles a team of scientists, clinicians, and technologists who collaborate with leading researchers to create evidence-based treatments. These digital solutions are designed to empower patients, allowing them to manage their health more effectively and regain control over their illnesses. By providing transformative therapeutic options, Swing Therapeutics seeks to enhance the overall well-being of patients, enabling them to lead healthier and more fulfilling lives.

Woebot Health

Series B in 2021
Woebot Health is a digital mental healthcare provider that offers a platform designed to deliver personalized support and guidance. Utilizing advanced artificial intelligence and natural language processing, Woebot Health incorporates clinically proven therapeutic techniques into its services. The centerpiece of its offering is Woebot, an engaging relational agent that facilitates continuous, empathic, and user-friendly interactions. This innovative approach allows individuals and organizations to access effective mental health support seamlessly, fitting into daily life and providing help whenever needed. Woebot Health aims to enhance mental well-being through scalable digital tools, making mental health resources more accessible to a broad audience.

Intuition

Series A in 2021
Intuition is an AI-powered platform that offers employee engagement solutions.

Thrive Global

Series C in 2021
Thrive Global is a behavior change technology company founded by Arianna Huffington in 2016, with headquarters in New York City and additional offices in San Francisco, Athens, Bucharest, Dublin, and Melbourne. The company aims to transform workplace culture and personal well-being by providing a platform that combines data, storytelling, and actionable strategies known as Microsteps. Thrive Global offers science-based solutions designed to reduce stress and burnout, promoting improved mental and physical health for individuals, corporations, and communities. The company's mission focuses on fostering a healthier relationship with technology and enhancing overall performance and purpose, ultimately challenging the notion that burnout is an inevitable part of success.

Zeitworks

Venture Round in 2021
Zeitworks Technologies, Inc., established in 2020 and headquartered in Seattle, Washington, with an additional office in Los Angeles, California, specializes in developing a SaaS platform for business process improvement. The platform employs machine learning to analyze and enhance customers' business processes, measuring execution step-by-step through the paths workers naturally take. It operates without disrupting users or requiring system integrations, making it currently available to select pilot customers.

Colossal Laboratories & Biosciences

Seed Round in 2021
Colossal Laboratories & Biosciences is a bioscience and genetic engineering company dedicated to addressing extinction and biodiversity loss through innovative gene editing technologies, primarily CRISPR. The company focuses on reviving extinct species, such as the woolly mammoth, while also working to protect critically endangered species and restore vital ecosystems. By employing advanced genetic techniques, Colossal aims to create solutions that not only facilitate the repopulation of ecosystems but also contribute to the sustainability of life on Earth. Through its pioneering efforts, Colossal aspires to tackle pressing environmental challenges and support the future of both ecological health and human necessities.

AppliedVR

Series A in 2021
AppliedVR, Inc. is a Los Angeles-based company that specializes in virtual reality solutions aimed at enhancing patient experiences in healthcare, particularly for pain and anxiety management in settings such as hospitals and surgery centers. Founded in 2013, AppliedVR has established strategic partnerships with institutions like Cedars-Sinai and Children's Hospital Los Angeles. The company's flagship product, EaseVRx, is a pioneering VR-based prescription therapeutic that has received Breakthrough Device Designation from the FDA. This innovative treatment leverages principles of cognitive behavioral therapy and mindfulness to help patients manage chronic pain by changing their pain perception and fostering new coping skills. EaseVRx allows patients to self-administer therapy at home, facilitating remote care and improving access to effective pain management solutions. Through its clinically validated and comprehensive approach, AppliedVR seeks to address the complexities of chronic pain and enhance overall quality of life for patients.

Blue Note Therapeutics

Series A in 2021
Blue Note Therapeutics, established in 2018 and headquartered in San Francisco, specializes in digital therapeutics for mental health care within cancer patients. The company's platform delivers evidence-based interventions via software programs, enabling physicians to treat medical conditions as primary or supplementary therapies using mobile devices. Blue Note collaborates with medical researchers and patient advocacy groups to ensure its solutions reach a wide range of patients.

Outside

Series B in 2021
Outside operator of a digital media company planned to produce a collection of an active lifestyle and sports material. The company publishes lifestyle content such as storytelling, meal plans, gear reviews, online courses, films, TV series, discounted event access, magazines, and more across television, mobile, desktop, and print outlets from a variety of brands, allowing people to access a reliable website for endurance sports information.

Arrive Health

Series B in 2021
Arrive Health, founded in 2013 and based in Denver, Colorado, specializes in providing access to affordable, quality healthcare by delivering precise, patient-specific cost and coverage information. The company has developed integrated technologies that enhance health system workflows, enabling seamless communication among providers, care teams, and patients. Through its extensive network of payers, pharmacy benefit managers, and IT vendors, Arrive Health facilitates discussions about affordability and access by alerting healthcare professionals to coverage restrictions, lower-cost alternatives, and location-based care options. This helps providers make informed decisions, ultimately reducing friction throughout the care continuum.

NextStep

Venture Round in 2021
NextStep is an information technology company based in Seattle, Washington, founded in 2018. It specializes in providing training and job placement services through a mobile application platform. The company's platform offers online certified nursing assistant (CNA) training and placement programs, as well as recruitment, training, and placement for various entry-level healthcare jobs such as community health workers, home health aides, and medical assistants. This enables individuals to quickly and affordably reskill themselves while helping employers in the healthcare sector find skilled employees.

Pear Therapeutics

Series D in 2020
Pear Therapeutics, Inc. is a Boston-based commercial-stage healthcare company specializing in software-based digital therapeutics, also known as Prescription Digital Therapeutics (PDTs). Founded in 2013, the company develops clinically validated software solutions designed to treat a range of behavioral health disorders, including addiction, anxiety, depression, and chronic insomnia. Its suite of products includes mobile digital therapies that reward patients for engagement, and specific tools like reSET and reSET-O, aimed at treating substance use disorders. The company also offers Somryst, which provides neurobehavioral interventions for insomnia, and operates PearConnect, a patient services center that connects patients with advocates and resources, ensuring support throughout their treatment journey. Pear Therapeutics aims to enhance treatment outcomes by integrating digital therapies with pharmaceuticals and providing comprehensive support for patients, clinicians, and payors.

Genesis Therapeutics

Series A in 2020
Genesis Therapeutics Inc. is a biotechnology company focused on developing small molecule drug candidates aimed at treating patients with severe and debilitating disorders. Established in 2019 and headquartered in South San Francisco, California, the company utilizes a proprietary artificial intelligence platform that integrates deep neural networks, biophysical simulation techniques, and scalable computing infrastructure. This innovative approach enhances the efficiency and accuracy of drug discovery and molecular design, allowing for improved molecular generation and property prediction. By leveraging these advanced technologies, Genesis Therapeutics seeks to transform the drug development process, ultimately aiming to optimize clinical outcomes for patients in need of effective therapies.

Robust.AI

Series A in 2020
Robust.AI, founded by Anthony Jules in 2019 and based in San Carlos, California, specializes in developing a robot cognitive platform that aims to solve complex robotics problems and make mobile robots widely usable across various industries. The company's technology combines AI, robotics, and human-centered design to create collaborative mobile robots that are safe, autonomous, and easy to integrate into existing workflows. Robust.AI has introduced two key products: Grace, a software suite, and Carter, a hardware concept. These innovations are particularly targeted at the warehousing industry, where automation is currently underutilized despite significant labor shortages impacting global supply chains.

Freeletics

Series B in 2020
Freeletics GmbH is a digital fitness company based in Munich, Germany, that develops and operates a fitness application designed to enhance physical fitness and mental strength. Founded in 2013, Freeletics provides personalized, AI-powered coaching in fitness, health, nutrition, and mindset through its app. The platform offers tailored training programs and nutrition coaching, allowing users to engage in workouts without the need for equipment or a gym. By focusing on individual potential, Freeletics aims to help users improve their physical fitness, mental resilience, and overall confidence, empowering them to achieve their personal health and lifestyle goals.

Outside

Series A in 2020
Outside operator of a digital media company planned to produce a collection of an active lifestyle and sports material. The company publishes lifestyle content such as storytelling, meal plans, gear reviews, online courses, films, TV series, discounted event access, magazines, and more across television, mobile, desktop, and print outlets from a variety of brands, allowing people to access a reliable website for endurance sports information.

Zeitworks

Seed Round in 2020
Zeitworks Technologies, Inc., established in 2020 and headquartered in Seattle, Washington, with an additional office in Los Angeles, California, specializes in developing a SaaS platform for business process improvement. The platform employs machine learning to analyze and enhance customers' business processes, measuring execution step-by-step through the paths workers naturally take. It operates without disrupting users or requiring system integrations, making it currently available to select pilot customers.

The Meta

Series A in 2020
The Meta is an e-sports training platform tailored for gamers, particularly those engaged in first-person shooter games. The company leverages a combination of sports performance science, game development techniques, and machine learning to enhance gamers' skills, aiming to transform them into highly proficient players. By focusing on the competitive aspects of gaming, The Meta provides tools that help users improve their gameplay and advance in competitive rankings. The platform addresses the needs of the vast audience of gamers seeking to elevate their performance and achieve mastery in their respective games.

Mahana Therapeutics

Series A in 2020
Mahana Therapeutics, Inc. is a company focused on developing digital treatments for individuals with chronic health conditions, particularly gastrointestinal diseases. Its flagship offering, Parallel, is a clinically validated, minimal-contact digital program specifically designed for patients suffering from irritable bowel syndrome (IBS). The program aims to deliver both physical and psychological support to enhance patient well-being. Founded in 2018 and headquartered in San Francisco, California, Mahana Therapeutics also maintains an office in London, United Kingdom. The company was previously known as Mahana Health, Inc. before rebranding in July 2019.

NextStep

Venture Round in 2020
NextStep is an information technology company based in Seattle, Washington, founded in 2018. It specializes in providing training and job placement services through a mobile application platform. The company's platform offers online certified nursing assistant (CNA) training and placement programs, as well as recruitment, training, and placement for various entry-level healthcare jobs such as community health workers, home health aides, and medical assistants. This enables individuals to quickly and affordably reskill themselves while helping employers in the healthcare sector find skilled employees.

Mahana Therapeutics

Seed Round in 2020
Mahana Therapeutics, Inc. is a company focused on developing digital treatments for individuals with chronic health conditions, particularly gastrointestinal diseases. Its flagship offering, Parallel, is a clinically validated, minimal-contact digital program specifically designed for patients suffering from irritable bowel syndrome (IBS). The program aims to deliver both physical and psychological support to enhance patient well-being. Founded in 2018 and headquartered in San Francisco, California, Mahana Therapeutics also maintains an office in London, United Kingdom. The company was previously known as Mahana Health, Inc. before rebranding in July 2019.

Cadence Neuroscience

Series A in 2019
Cadence Neuroscience, Inc. is an early-stage company founded in 2017 and headquartered in Redmond, Washington. It specializes in developing innovative medical device therapies aimed at treating epilepsy, central pain, and other neurological disorders. The company’s core technology, developed at the Mayo Clinic, is currently under clinical evaluation. Cadence Neuroscience's medical devices are designed to detect specific brain signals and deliver targeted electrical stimulation, allowing for tailored brain stimulation therapies. This approach enhances seizure control and aims to improve treatment outcomes for patients with neurological issues compared to existing protocols.

NextStep

Series A in 2019
NextStep is an information technology company based in Seattle, Washington, founded in 2018. It specializes in providing training and job placement services through a mobile application platform. The company's platform offers online certified nursing assistant (CNA) training and placement programs, as well as recruitment, training, and placement for various entry-level healthcare jobs such as community health workers, home health aides, and medical assistants. This enables individuals to quickly and affordably reskill themselves while helping employers in the healthcare sector find skilled employees.

Arrive Health

Series A in 2019
Arrive Health, founded in 2013 and based in Denver, Colorado, specializes in providing access to affordable, quality healthcare by delivering precise, patient-specific cost and coverage information. The company has developed integrated technologies that enhance health system workflows, enabling seamless communication among providers, care teams, and patients. Through its extensive network of payers, pharmacy benefit managers, and IT vendors, Arrive Health facilitates discussions about affordability and access by alerting healthcare professionals to coverage restrictions, lower-cost alternatives, and location-based care options. This helps providers make informed decisions, ultimately reducing friction throughout the care continuum.

Wade & Wendy

Series A in 2019
Wade & Wendy, Inc. is a New York-based company that specializes in enhancing the hiring process through artificial intelligence. Founded in June 2015 by Josh Brandoff, Adrian von der Osten, and Drew Austin, the company develops two primary chatbots: Wendy, which assists employers by screening applicants on career websites and making hiring recommendations, and Wade, which supports job seekers by recording their data and identifying suitable job opportunities. The platform leverages machine intelligence and big data to provide insights that facilitate more informed hiring decisions, fostering a more engaging and human-centric recruitment experience for both job seekers and hiring teams.

Pear Therapeutics

Series C in 2019
Pear Therapeutics, Inc. is a Boston-based commercial-stage healthcare company specializing in software-based digital therapeutics, also known as Prescription Digital Therapeutics (PDTs). Founded in 2013, the company develops clinically validated software solutions designed to treat a range of behavioral health disorders, including addiction, anxiety, depression, and chronic insomnia. Its suite of products includes mobile digital therapies that reward patients for engagement, and specific tools like reSET and reSET-O, aimed at treating substance use disorders. The company also offers Somryst, which provides neurobehavioral interventions for insomnia, and operates PearConnect, a patient services center that connects patients with advocates and resources, ensuring support throughout their treatment journey. Pear Therapeutics aims to enhance treatment outcomes by integrating digital therapies with pharmaceuticals and providing comprehensive support for patients, clinicians, and payors.

AI Redefined

Seed Round in 2018
AI Redefined is a software company focused on advancing machine learning research and applications. The company aims to enhance the interaction between humans and artificial intelligence, fostering continuous learning and collaboration. Its primary offering, Cogment, is an open-source framework designed for high-performance multi-agent training, enabling both AIs and humans to learn together in a shared environment. The platform includes tools for adaptive learning and fine-tuning, facilitating seamless integration and interaction between technology and users. By providing a universal and secure digital space for ongoing collaboration, AI Redefined is dedicated to shaping a smarter future through effective human-AI cooperation.

Freeletics

Series A in 2018
Freeletics GmbH is a digital fitness company based in Munich, Germany, that develops and operates a fitness application designed to enhance physical fitness and mental strength. Founded in 2013, Freeletics provides personalized, AI-powered coaching in fitness, health, nutrition, and mindset through its app. The platform offers tailored training programs and nutrition coaching, allowing users to engage in workouts without the need for equipment or a gym. By focusing on individual potential, Freeletics aims to help users improve their physical fitness, mental resilience, and overall confidence, empowering them to achieve their personal health and lifestyle goals.

NextStep

Seed Round in 2018
NextStep is an information technology company based in Seattle, Washington, founded in 2018. It specializes in providing training and job placement services through a mobile application platform. The company's platform offers online certified nursing assistant (CNA) training and placement programs, as well as recruitment, training, and placement for various entry-level healthcare jobs such as community health workers, home health aides, and medical assistants. This enables individuals to quickly and affordably reskill themselves while helping employers in the healthcare sector find skilled employees.

Perceptive Automata

Series A in 2018
Perceptive Automata, Inc. is a technology company specializing in machine learning and computer vision solutions aimed at predicting human behavior in the context of automated driving. Founded in 2014 and located in Somerville, Massachusetts, the company addresses the complex challenges associated with the safe deployment of highly automated and fully autonomous vehicles, particularly in urban settings. Its advanced AI inference models allow vehicles to anticipate the actions of pedestrians, cyclists, and other drivers, enhancing safety and enabling smoother navigation in human-dominated environments. By integrating its software into autonomous driving systems, Perceptive Automata facilitates a more natural driving experience, which is crucial for the acceptance of autonomous vehicles and robotaxi services. The company's team comprises experts from prestigious institutions such as Harvard, MIT, and Stanford, reflecting a strong foundation in neuroscience and artificial intelligence.

Pymetrics

Series B in 2018
Pymetrics, Inc. is a company that specializes in neuroscience-based assessment and prediction technology aimed at transforming hiring, retention, and employee development processes. Founded in 2013 and headquartered in New York City, Pymetrics offers solutions that combine cognitive and emotional assessments with a dynamic recommendation engine. This platform utilizes artificial intelligence and machine learning to analyze behavioral data collected from successful professionals across various roles, helping organizations identify key traits that differentiate high performers from the general population. By focusing on improving the recruitment process, Pymetrics aims to enhance accuracy and reduce bias in hiring decisions.

Freeletics

Venture Round in 2018
Freeletics GmbH is a digital fitness company based in Munich, Germany, that develops and operates a fitness application designed to enhance physical fitness and mental strength. Founded in 2013, Freeletics provides personalized, AI-powered coaching in fitness, health, nutrition, and mindset through its app. The platform offers tailored training programs and nutrition coaching, allowing users to engage in workouts without the need for equipment or a gym. By focusing on individual potential, Freeletics aims to help users improve their physical fitness, mental resilience, and overall confidence, empowering them to achieve their personal health and lifestyle goals.

Embodied

Series A in 2018
Embodied, Inc. is a robotics company based in Pasadena, California, specializing in the development of personal companion robots aimed at enhancing care and wellness. Founded in 2016 and formerly known as CareBots, Inc., the company has created Moxie, an interactive robot designed for children that promotes social, emotional, and cognitive development through play-based learning. Drawing on over 14 years of research in socially assistive robotics from the University of Southern California and extensive experience in consumer robotics, Embodied combines advanced artificial intelligence with engaging storytelling and animation techniques. The company's mission is to improve the quality of life for individuals and families by providing life-like, interactive robots that serve as motivators, coaches, and companions, empowering users to improve their own well-being.

Wisdo Health

Convertible Note in 2018
Wisdo Health is an AI-powered social health platform focused on enhancing mental and physical well-being by fostering meaningful connections among users. The company offers an evidence-based peer support and benefits navigation platform that addresses the detrimental effects of social isolation and loneliness. By connecting individuals with shared experiences, Wisdo Health aims to improve health outcomes and reduce medical costs. The platform empowers users to learn from one another, facilitating personal growth and resilience in the face of life’s challenges and opportunities.

Thrive Global

Series B in 2018
Thrive Global is a behavior change technology company founded by Arianna Huffington in 2016, with headquarters in New York City and additional offices in San Francisco, Athens, Bucharest, Dublin, and Melbourne. The company aims to transform workplace culture and personal well-being by providing a platform that combines data, storytelling, and actionable strategies known as Microsteps. Thrive Global offers science-based solutions designed to reduce stress and burnout, promoting improved mental and physical health for individuals, corporations, and communities. The company's mission focuses on fostering a healthier relationship with technology and enhancing overall performance and purpose, ultimately challenging the notion that burnout is an inevitable part of success.

Akili Interactive

Series C in 2018
Akili Interactive Labs, Inc., established in 2011 and headquartered in Boston, Massachusetts, specializes in developing digital medicine solutions. The company's core business involves creating video game-based technology to assess and enhance cognitive abilities. Akili's broad pipeline focuses on treating cognitive deficiencies and improving symptoms associated with various medical conditions, such as ADHD, MDD, ASD, and inflammatory diseases.

Woebot Health

Series A in 2018
Woebot Health is a digital mental healthcare provider that offers a platform designed to deliver personalized support and guidance. Utilizing advanced artificial intelligence and natural language processing, Woebot Health incorporates clinically proven therapeutic techniques into its services. The centerpiece of its offering is Woebot, an engaging relational agent that facilitates continuous, empathic, and user-friendly interactions. This innovative approach allows individuals and organizations to access effective mental health support seamlessly, fitting into daily life and providing help whenever needed. Woebot Health aims to enhance mental well-being through scalable digital tools, making mental health resources more accessible to a broad audience.

Halo Neuro

Series B in 2018
Halo Neuro, established in 2013 and headquartered in San Francisco, specializes in developing neurotechnology systems. Its flagship product, Halo Sport, employs a technique called Neuropriming, which combines electrical stimulation with movement-based training to enhance skill and strength acquisition in elite athletes. This process temporarily boosts the brain's learning capacity, or 'hyperplasticity', refining its ability to adapt to training. The company aims to help individuals unlock their full potential through innovative brain stimulation technology.

Pear Therapeutics

Series B in 2018
Pear Therapeutics, Inc. is a Boston-based commercial-stage healthcare company specializing in software-based digital therapeutics, also known as Prescription Digital Therapeutics (PDTs). Founded in 2013, the company develops clinically validated software solutions designed to treat a range of behavioral health disorders, including addiction, anxiety, depression, and chronic insomnia. Its suite of products includes mobile digital therapies that reward patients for engagement, and specific tools like reSET and reSET-O, aimed at treating substance use disorders. The company also offers Somryst, which provides neurobehavioral interventions for insomnia, and operates PearConnect, a patient services center that connects patients with advocates and resources, ensuring support throughout their treatment journey. Pear Therapeutics aims to enhance treatment outcomes by integrating digital therapies with pharmaceuticals and providing comprehensive support for patients, clinicians, and payors.

Level Ex

Series A in 2017
Level Ex, Inc. is a Chicago-based company that specializes in developing virtual surgery mobile applications and professional medical video games aimed at physicians. Founded in 2015, the company focuses on enhancing surgical training through innovative platforms, such as Virtual Technique Guides, which leverage multiplayer interactivity to facilitate virtual procedures in collaboration with medical device representatives. One of its notable products, Airway EX, is designed to help physicians master critical skills in endoscopic and interventional airway procedures, addressing various medical challenges such as obstructing tumors and complex intubations. By employing advanced video game technology and cognitive neuroscience, Level Ex enables healthcare professionals to stay current with rare cases, new medical devices, and evolving drug therapies, ultimately improving their surgical capabilities and decision-making skills.

Pymetrics

Series A in 2017
Pymetrics, Inc. is a company that specializes in neuroscience-based assessment and prediction technology aimed at transforming hiring, retention, and employee development processes. Founded in 2013 and headquartered in New York City, Pymetrics offers solutions that combine cognitive and emotional assessments with a dynamic recommendation engine. This platform utilizes artificial intelligence and machine learning to analyze behavioral data collected from successful professionals across various roles, helping organizations identify key traits that differentiate high performers from the general population. By focusing on improving the recruitment process, Pymetrics aims to enhance accuracy and reduce bias in hiring decisions.

Augment CXM

Seed Round in 2017
Augment CXM is a pioneering company in the customer experience management sector, utilizing a patented semantic neural network to enhance customer interactions. The company develops an advanced platform that aids customer service agents by providing real-time monitoring of digital and voice communications, offering actionable insights to improve key performance indicators. This innovative approach has demonstrated significant results for its clients, including a 30% increase in agent efficiency, a 44% boost in sales conversion rates, and a 40% rise in customer satisfaction. Augment CXM serves a diverse range of prominent brands, positioning itself as a leader in transforming the customer experience landscape through artificial intelligence-driven solutions.

Aira

Series B in 2017
Aira is a company dedicated to enhancing accessibility for individuals who are blind or have low vision. It offers remote visual interpretation services through a user-friendly app that connects users with highly trained Visual Interpreters. By utilizing a smartphone's camera, users can stream live video to these interpreters, who assist them in navigating various daily activities safely and efficiently. Additionally, Aira has developed wearable smart glasses that link users to a network of certified agents, providing real-time visual assistance via an augmented reality dashboard. This innovative approach empowers visually impaired individuals to perform tasks such as navigating busy streets and recognizing faces, ultimately promoting greater mobility and independence in their everyday lives.

Two Bit Circus

Series B in 2017
Two Bit Circus, Inc. is an entertainment company based in Los Angeles, California, founded in 2012. It specializes in creating and operating micro-amusement parks that blend modern interactive technology with the classic charm of circus and carnival experiences. These one-acre venues are designed to provide unique recreational opportunities, featuring immersive games, interactive amusements, stage shows, and food offerings. The company also runs a Park as a Platform program that allows game developers to create location-based entertainment. In addition to its physical installations, Two Bit Circus sells merchandise online, including T-shirts and stickers. The company is committed to fostering community engagement and innovation through its nonprofit arm, the Two Bit Circus Foundation, which promotes STEAM education and access to maker tools for schools and youth.

Halo Neuro

Series A in 2016
Halo Neuro, established in 2013 and headquartered in San Francisco, specializes in developing neurotechnology systems. Its flagship product, Halo Sport, employs a technique called Neuropriming, which combines electrical stimulation with movement-based training to enhance skill and strength acquisition in elite athletes. This process temporarily boosts the brain's learning capacity, or 'hyperplasticity', refining its ability to adapt to training. The company aims to help individuals unlock their full potential through innovative brain stimulation technology.

Pear Therapeutics

Series A in 2016
Pear Therapeutics, Inc. is a Boston-based commercial-stage healthcare company specializing in software-based digital therapeutics, also known as Prescription Digital Therapeutics (PDTs). Founded in 2013, the company develops clinically validated software solutions designed to treat a range of behavioral health disorders, including addiction, anxiety, depression, and chronic insomnia. Its suite of products includes mobile digital therapies that reward patients for engagement, and specific tools like reSET and reSET-O, aimed at treating substance use disorders. The company also offers Somryst, which provides neurobehavioral interventions for insomnia, and operates PearConnect, a patient services center that connects patients with advocates and resources, ensuring support throughout their treatment journey. Pear Therapeutics aims to enhance treatment outcomes by integrating digital therapies with pharmaceuticals and providing comprehensive support for patients, clinicians, and payors.

Akili Interactive

Series B in 2016
Akili Interactive Labs, Inc., established in 2011 and headquartered in Boston, Massachusetts, specializes in developing digital medicine solutions. The company's core business involves creating video game-based technology to assess and enhance cognitive abilities. Akili's broad pipeline focuses on treating cognitive deficiencies and improving symptoms associated with various medical conditions, such as ADHD, MDD, ASD, and inflammatory diseases.

Level Ex

Seed Round in 2016
Level Ex, Inc. is a Chicago-based company that specializes in developing virtual surgery mobile applications and professional medical video games aimed at physicians. Founded in 2015, the company focuses on enhancing surgical training through innovative platforms, such as Virtual Technique Guides, which leverage multiplayer interactivity to facilitate virtual procedures in collaboration with medical device representatives. One of its notable products, Airway EX, is designed to help physicians master critical skills in endoscopic and interventional airway procedures, addressing various medical challenges such as obstructing tumors and complex intubations. By employing advanced video game technology and cognitive neuroscience, Level Ex enables healthcare professionals to stay current with rare cases, new medical devices, and evolving drug therapies, ultimately improving their surgical capabilities and decision-making skills.

Eyefluence

Series B in 2015
Eyefluence, Inc. is a technology company specializing in eye-interaction solutions for augmented reality (AR), virtual reality (VR), and mixed reality (MR) head-mounted displays (HMDs). Founded in 2013 and headquartered in Reno, Nevada, Eyefluence integrates its innovative technology with HMDs to enable users to control devices through eye movements, leveraging insights from eye biomechanics and the eye-brain connection. This approach allows for a natural and intuitive interaction, enhancing user experiences in the AR, VR, and MR environments. The company boasts a robust intellectual property portfolio with over 30 patents granted or pending, reflecting its commitment to advancing eye-tracking technology. Led by experienced entrepreneurs, Eyefluence collaborates with both startups and established enterprises to promote the adoption of smart glasses across various sectors, including consumer, industrial, and government applications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.